R
Ru-xiang Xu
Researcher at Southern Medical University
Publications - 57
Citations - 966
Ru-xiang Xu is an academic researcher from Southern Medical University. The author has contributed to research in topics: Neural stem cell & Transplantation. The author has an hindex of 18, co-authored 54 publications receiving 859 citations.
Papers
More filters
Journal ArticleDOI
Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury
TL;DR: BMMSCs transplantation improves neurological function in patients with complete and chronic cervical SCI, providing valuable information on applications of BMMSCs for the treatment of SCI.
Journal ArticleDOI
Adenoviral‐mediated interleukin‐18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats
Gang Xu,Xiao-dan Jiang,Ying Xu,Jing Zhang,Fanheng Huang,Zhen-Zhou Chen,De-Xiang Zhou,Jiang-Hua Shang,Yu-Xi Zou,Ying-qian Cai,Sheng-bin Kou,Yi-zhao Chen,Ru-xiang Xu,Yanjun Zeng +13 more
TL;DR: When used in conjunction with MSCs as targeting vehicles in vivo, IL‐18 may offer a promising new treatment option for malignant glioma.
Journal ArticleDOI
NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats.
Aijia Shang,Sun-Quan Hong,Qiang Xu,Hang-Yan Wang,Ying Yang,Zhongfeng Wang,Bai-Nan Xu,Xiao-dan Jiang,Ru-xiang Xu +8 more
TL;DR: Results show that NT-3 enhanced the therapeutic effects of HUMSCs after clip injury of the spinal cord.
Journal ArticleDOI
Neural differentiation ability of mesenchymal stromal cells from bone marrow and adipose tissue: a comparative study.
TL;DR: The study suggests that the proliferation ability of ADSC is superior to that of BMSC, and may have wide potential for treating central nervous system (CNS) diseases.
Journal ArticleDOI
Functional endothelial progenitor cells derived from adipose tissue show beneficial effect on cell therapy of traumatic brain injury
TL;DR: It is suggested that adult AT derived stem cells can be induced to functional EPCs and have beneficial effect on cell therapy.